Epoxide hydrolases: biochemistry and molecular biology.
暂无分享,去创建一个
[1] I. Fleming,et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. , 2000, Trends in cardiovascular medicine.
[2] C. J. Omiecinski,et al. Post-transcriptional regulation of human microsomal epoxide hydrolase. , 1998, Pharmacogenetics.
[3] A. Gaedigk,et al. Epitope mapping studies with human anti-cytochrome P450 3A antibodies. , 1996, Molecular pharmacology.
[4] B. Borhan,et al. Improved radiolabeled substrates for soluble epoxide hydrolase. , 1995, Analytical biochemistry.
[5] D. Reynaud,et al. Hepoxilin A3 formation in the rat pineal gland selectively utilizes (12S)-hydroperoxyeicosatetraenoic acid (HPETE), but not (12R)-HPETE. , 1994, The Journal of biological chemistry.
[6] E. Vesell. Genetic factors that regulate cytosolic epoxide hydrolase activity in normal human lymphocytes. , 1991, Annales de genetique.
[7] R. Armstrong,et al. Mechanism of microsomal epoxide hydrolase. Semifunctional site-specific mutants affecting the alkylation half-reaction. , 1998, Biochemistry.
[8] R. Armstrong,et al. Enzyme-catalyzed detoxication reactions: mechanisms and stereochemistry. , 1987, CRC critical reviews in biochemistry.
[9] E. Corey,et al. Hepoxilin A3 (HxA3) is formed by the rat aorta and is metabolized into HxA3-C, a glutathione conjugate. , 1991, Biochimica et biophysica acta.
[10] T. Kunkel,et al. Symposium overview: the role of genetic polymorphism and repair deficiencies in environmental disease. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[11] Chi‐Huey Wong,et al. Development of selective tight-binding inhibitors of leukotriene A4 hydrolase. , 1993, Journal of medicinal chemistry.
[12] G. Prestwich,et al. Cyclopropyl oxiranes: reversible inhibitors of cytosolic and microsomal epoxide hydrolases. , 1985, Archives of biochemistry and biophysics.
[13] D. Christianson,et al. Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] F. Oesch,et al. Asp, Asp, and His Form the Catalytic Triad of Rat Soluble Epoxide Hydrolase (*) , 1996, The Journal of Biological Chemistry.
[15] J. Depierre,et al. Cytosolic epoxide hydrolase. , 1988, Chemico-biological interactions.
[16] R. Holubkov,et al. Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. , 1993, Pharmacogenetics.
[17] L. Holmes,et al. Phenytoin embryopathy: effect of epoxide hydrolase inhibitor on phenytoin exposure in utero in C57BL/6J mice. , 1995, Biochemical and molecular medicine.
[18] M. Pirmohamed,et al. Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene. , 1996, The Journal of pharmacology and experimental therapeutics.
[19] B. Hammock,et al. Cloning and expression of soluble epoxide hydrolase from potato. , 1994, The Plant journal : for cell and molecular biology.
[20] D. V. Van Dyke,et al. Differences in Phenytoin Biotransformation and Susceptibility to Congenital Malformations: A Review , 1991, DICP : the annals of pharmacotherapy.
[21] J. Meijer,et al. Identification and Functional Characterization of Human Soluble Epoxide Hydrolase Genetic Polymorphisms* , 2000, The Journal of Biological Chemistry.
[22] D. Jerina,et al. Distinct rat hepatic microsomal epoxide hydrolases catalyze the hydration of cholesterol 5,6 alpha-oxide and certain xenobiotic alkene and arene oxides. , 1983, Archives of biochemistry and biophysics.
[23] B. Borhan,et al. Characterization of the cytosolic epoxide hydrolase-catalyzed hydration products from 9,10:12,13-diepoxy stearic esters. , 1992, Archives of biochemistry and biophysics.
[24] H. Yamazaki,et al. Activation and detoxication of aflatoxin B1. , 1998, Mutation research.
[25] C. Hassett,et al. The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. , 1994, Genomics.
[26] S. K. Yang,et al. Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes. , 1987, Molecular pharmacology.
[27] F. Oesch,et al. Gene evolution of epoxide hydrolases and recommended nomenclature. , 1995, DNA and cell biology.
[28] A. Sevanian,et al. Cholesterol epoxide is a direct-acting mutagen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Depierre,et al. Proliferation of peroxisomes and induction of cytosolic and microsomal epoxide hydrolases in different strains of mice and rats after dietary treatment with clofibrate. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.
[30] D. Zeldin,et al. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. , 1993, The Journal of biological chemistry.
[31] E. Dietze,et al. Inhibition of epoxide hydrolase from human, monkey, bovine, rabbit and murine liver by trans-3-phenylglycidols. , 1993, Comparative biochemistry and physiology. B, Comparative biochemistry.
[32] C. Hassett,et al. Human microsomal epoxide hydrolase: 5'-flanking region genetic polymorphisms. , 1998, Carcinogenesis.
[33] F. Fitzpatrick,et al. Enzymatic hydration of leukotriene A4. Purification and characterization of a novel epoxide hydrolase from human erythrocytes. , 1985, The Journal of biological chemistry.
[34] J. Haeggström,et al. Structure, function, and regulation of leukotriene A4 hydrolase. , 2000, American journal of respiratory and critical care medicine.
[35] C. von Schacky,et al. The human leukotriene A4 hydrolase gene is expressed in two alternatively spliced mRNA forms. , 1996, The Biochemical journal.
[36] B. Hammock,et al. cDNA cloning and expression of a soluble epoxide hydrolase from human liver. , 1993, Archives of biochemistry and biophysics.
[37] Shirley Dex,et al. JR 旅客販売総合システム(マルス)における運用及び管理について , 1991 .
[38] S. Nigam,et al. Hepoxilin signaling in intact human neutrophils: biphasic elevation of intracellular calcium by unesterified hepoxilin A3 , 1999, FEBS letters.
[39] F. Oesch,et al. Rat and human liver cytosolic epoxide hydrolases: evidence for multiple forms at level of protein and mRNA. , 1990, Environmental health perspectives.
[40] J. S. Sidhu,et al. Effects of chemical inducers on human microsomal epoxide hydrolase in primary hepatocyte cultures. , 1998, Biochemical pharmacology.
[41] D. Grant,et al. Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. , 1994, Pharmacogenetics.
[42] E. Dietze,et al. Spectrophotometric substrates for cytosolic epoxide hydrolase. , 1994, Analytical biochemistry.
[43] W. S. Lee,et al. Purification of hepoxilin epoxide hydrolase from rat liver. , 1989, The Journal of biological chemistry.
[44] R. Busse,et al. EDHF: a cytochrome P450 metabolite in coronary arteries. , 2000, Seminars in perinatology.
[45] A. Sevanian,et al. The cytotoxic and mutagenic properties of cholesterol oxidation products. , 1986, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[46] F. Oesch,et al. Structure of Aspergillus niger epoxide hydrolase at 1.8 A resolution: implications for the structure and function of the mammalian microsomal class of epoxide hydrolases. , 2000, Structure.
[47] S. Knowles,et al. Anticonvulsant Hypersensitivity Syndrome , 1999, Drug safety.
[48] C. Kasper,et al. Expression of rat microsomal epoxide hydrolase in Escherichia coli. Identification of a histidyl residue essential for catalysis. , 1993, The Journal of biological chemistry.
[49] D. Reynaud,et al. Hepoxilin A3 is the endogenous lipid mediator opposing hypotonic swelling of intact human platelets. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. Jackson,et al. Induction of microsomal epoxide hydrolase by nitrosamines in rat liver. Effect on messenger ribonucleic acids. , 1988, Biochemical pharmacology.
[51] T. Fujita,et al. Induction of rat liver microsomal cytochrome P-450 isozymes and epoxide hydrolase by a series of 4'-substituted-2,3,4,5-tetrachlorobiphenyls. , 1988, Toxicology.
[52] J. Haeggström,et al. Novel structural and functional properties of leukotriene A4 hydrolase. Implications for the development of enzyme inhibitors. , 1994, Advances in prostaglandin, thromboxane, and leukotriene research.
[53] F. Oesch,et al. Endogenous role of microsomal epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution, immunological behaviour and purification of microsomal epoxide hydrolase with 16 alpha, 17 alpha-epoxyandrostene-3-one as substrate. , 1982, European journal of biochemistry.
[54] B. Hammock,et al. Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase , 1997, Nature Medicine.
[55] J. Muglia,et al. Anticonvulsant hypersensitivity syndrome. , 1995, Archives of internal medicine.
[56] B. Hammock,et al. Increased cholesterol epoxide hydrolase activity in clofibrate-fed animals. , 1988, Biochemical pharmacology.
[57] J. Haeggström,et al. Leukotriene A4 hydrolase: a critical role of glutamic acid-296 for the binding of bestatin. , 2000, The Biochemical journal.
[58] J. Depierre,et al. Subcellular and organ distribution of cholesterol epoxide hydrolase in the rat. , 1986, Biochimica et biophysica acta.
[59] F. Beland,et al. Mutagenicity of oxidized microsomal metabolites of 1-nitropyrene in Chinese hamster ovary cells. , 1990, Mutagenesis.
[60] B. Borhan,et al. Mechanism of Soluble Epoxide Hydrolase , 1995, The Journal of Biological Chemistry.
[61] N. Kitteringham,et al. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. , 1988, British journal of clinical pharmacology.
[62] F. Oesch,et al. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[63] D. Jerina,et al. Properties of liver microsomal cholesterol 5,6-oxide hydrolase. , 1985, Archives of biochemistry and biophysics.
[64] J. Leeder,et al. Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions. , 1992, The Journal of pharmacology and experimental therapeutics.
[65] O. Rådmark,et al. Leukotriene A4 hydrolase: analysis of some human tissues by radioimmunoassay. , 1989, Biochimica et biophysica acta.
[66] F. Gonzalez,et al. Targeted Disruption of the Microsomal Epoxide Hydrolase Gene , 1999, The Journal of Biological Chemistry.
[67] A. Elfarra,et al. Oxidation of butadiene monoxide to meso- and (+/-)-diepoxybutane by cDNA-expressed human cytochrome P450s and by mouse, rat, and human liver microsomes: evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes. , 1997, Archives of biochemistry and biophysics.
[68] D. Jerina,et al. Differential stereoselectivity of cytochromes P-450b and P-450c in the formation of naphthalene and anthracene 1,2-oxides. The role of epoxide hydrolase in determining the enantiomer composition of the 1,2-dihydrodiols formed. , 1985, The Journal of biological chemistry.
[69] J. Haeggström,et al. Leukotriene A4 hydrolase: structural and functional properties of the active center. , 1993, Journal of lipid mediators.
[70] C. Falany,et al. Glucocorticoid repression and basal regulation of the epoxide hydrolase promoter. , 1990, Archives of biochemistry and biophysics.
[71] J. Evans,et al. Cloning and characterization of the human leukotriene A4 hydrolase gene. , 1995, European journal of biochemistry.
[72] C-Y Chen,et al. Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma , 2000, British Journal of Cancer.
[73] B. Hammock,et al. Purification of microsomal epoxide hydrolase from liver of rhesus monkey: partial separation of cis- and trans-stilbene oxide hydrolase. , 1987, Archives of biochemistry and biophysics.
[74] C. J. Omiecinski,et al. Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. , 1997, Archives of Biochemistry and Biophysics.
[75] A. B. Graham,et al. Microsomal epoxide hydrolase of rat liver. Purification and characterization of enzyme fractions with different chromatographic characteristics. , 1986, The Biochemical journal.
[76] O. Mcbride,et al. Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells, and chromosomal localization. , 1988, The Journal of biological chemistry.
[77] F. Oesch,et al. Isolation and characterization of a cDNA encoding rat liver cytosolic epoxide hydrolase and its functional expression in Escherichia coli. , 1993, The Journal of biological chemistry.
[78] M. Pirmohamed,et al. Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. , 1995, Biochemical pharmacology.
[79] D. Phillips,et al. Further metabolism of diol-epoxides of chrysene and dibenz[a,c]anthracene to DNA binding species as evidenced by 32P-postlabelling analysis. , 1988, Carcinogenesis.
[80] C. J. Omiecinski,et al. Xenobiotic microsomal epoxide hydrolase: 5' sequence of the human gene. , 1989, Biochimica et biophysica acta.
[81] D. Jerina,et al. 7-Dehydrocholesterol 5,6 beta-oxide as a mechanism-based inhibitor of microsomal cholesterol oxide hydrolase. , 1986, The Journal of biological chemistry.
[82] S. Rappaport,et al. Measurement of benzene oxide in the blood of rats following administration of benzene. , 1997, Carcinogenesis.
[83] R. Combes,et al. Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase. , 1986, Mutagenesis.
[84] G. Bellucci,et al. Kinetics and stereochemistry of the microsomal epoxide hydrolase-catalyzed hydrolysis of cis-stilbene oxides. , 1994, Chirality.
[85] B D Hammock,et al. Potent urea and carbamate inhibitors of soluble epoxide hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[86] D. Zeldin,et al. Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis. , 1995, Archives of biochemistry and biophysics.
[87] H. Jörnvall,et al. Purification and initial characterization of microsomal epoxide hydrolase from the human adrenal gland. , 1994, Biochimica et biophysica acta.
[88] E. Dietze,et al. Inhibition of cytosolic epoxide hydrolase by trans-3-phenylglycidols. , 1991, Biochemical pharmacology.
[89] H. Liu,et al. Regulation of Leukotriene A4 Hydrolase Activity in Endothelial Cells by Phosphorylation* , 1997, The Journal of Biological Chemistry.
[90] J. Rydström,et al. Subcellular distribution, catalytic properties and partial purification of epoxide hydrolase in the human adrenal gland. , 1985, Chemico-biological interactions.
[91] P. Ferrara,et al. Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site. , 1998, The Biochemical journal.
[92] K. Andersson,et al. Studies on the intracellular distributions of soluble epoxide hydrolase and of catalase by digitonin-permeabilization of hepatocytes isolated from control and clofibrate-treated mice. , 1991, European journal of biochemistry.
[93] F. Oesch,et al. Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome b5, microsomal epoxide hydrolase, and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. , 1993, Toxicology and applied pharmacology.
[94] H. Glatt,et al. Genotoxicity characteristics of reverse diol-epoxides of chrysene. , 1993, Carcinogenesis.
[95] F. Guengerich,et al. Kinetics of hydrolysis and reaction of aflatoxin B1 exo-8,9-epoxide and relevance to toxicity and detoxication. , 1999, Drug metabolism reviews.
[96] F. Oesch,et al. Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins , 1994, FEBS letters.
[97] B. Borhan,et al. Molecular and Biochemical Evidence for the Involvement of the Asp-333–His-523 Pair in the Catalytic Mechanism of Soluble Epoxide Hydrolase (*) , 1995, The Journal of Biological Chemistry.
[98] G. Carlson. Metabolism of styrene oxide to styrene glycol by mouse liver and lung. , 1998, Journal of toxicology and environmental health. Part A.
[99] A. Sevanian,et al. Catalytic properties and inhibition of hepatic cholesterol-epoxide hydrolase. , 1986, The Journal of biological chemistry.
[100] W. Hinz,et al. Catalytic triad of microsomal epoxide hydrolase: replacement of Glu404 with Asp leads to a strongly increased turnover rate. , 1999, The Biochemical journal.
[101] J. Depierre,et al. Induction of cytosolic and microsomal epoxide hydrolases in mouse liver by peroxisome proliferators, with special emphasis on structural analogues of 2-ethylhexanoic acid. , 1988, Chemico-biological interactions.
[102] C. Hassett,et al. Rabbit microsomal epoxide hydrolase: isolation and characterization of the xenobiotic metabolizing enzyme cDNA. , 1989, Archives of biochemistry and biophysics.
[103] A. Elfarra,et al. Epoxide hydrolase-dependent metabolism of butadiene monoxide to 3-butene-1,2-diol in mouse, rat, and human liver. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[104] J. Meijer,et al. Structural characterization of the human soluble epoxide hydrolase gene (EPHX2). , 1996, Biochemical and biophysical research communications.
[105] A. Hinnen,et al. Heterologous expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae. Study of the valpromide-carbamazepine epoxide interaction. , 1991, Biochemical pharmacology.
[106] G. Carlson,et al. Pneumotoxicity and hepatotoxicity of styrene and styrene oxide. , 1996, Journal of toxicology and environmental health.
[107] J. Depierre,et al. Induction of cytosolic and microsomal epoxide hydrolases and proliferation of peroxisomes and mitochondria in mouse liver after dietary exposure to p-chlorophenoxyacetic acid, 2,4-dichlorophenoxyacetic acid and 2,4,5-trichlorophenoxyacetic acid. , 1987, Biochemical pharmacology.
[108] M. Hamberg,et al. Evidence for a carbocation intermediate in the enzymatic transformation of leukotriene A4 into leukotriene B4. , 1999, Advances in experimental medicine and biology.
[109] J. S. Sidhu,et al. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. , 1994, Human molecular genetics.
[110] P. Dayer,et al. Association between lung cancer and microsomal epoxide hydrolase genotypes. , 1998, Cancer research.
[111] M. Lieberman,et al. Mouse leukotriene A4 hydrolase is expressed at high levels in intestinal crypt cells and splenic lymphocytes. , 1999, Gene.
[112] F. Oesch,et al. Purification and characterization of rat-liver cytosolic epoxide hydrolase. , 1988, European journal of biochemistry.
[113] B. Hammock,et al. Inhibition of soluble and microsomal epoxide hydrolase by zinc and other metals. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[114] F. Oesch,et al. Rat cytosolic epoxide hydrolase. , 1986, Advances in experimental medicine and biology.
[115] S. G. Kim,et al. Differential induction of rat hepatic microsomal epoxide hydrolase and rGSTA2 by diazines: the role of cytochrome P450 2E1-mediated metabolic activation. , 1998, Chemico-biological interactions.
[116] W. Hinz,et al. Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substrates. , 1997, European journal of biochemistry.
[117] C. Pace-Asciak. Hepoxilins: a review on their cellular actions. , 1994, Biochimica et biophysica acta.
[118] S. Spielberg,et al. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. , 1988, The Journal of clinical investigation.
[119] F. Gonzalez,et al. Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2, and epoxide hydrolase. , 1996, Biochemistry.
[120] B. Hammock,et al. Inhibition of epoxide hydrolases and glutathione S-transferases by 2-, 3-, and 4-substituted derivatives of 4'-phenylchalcone and its oxide. , 1987, Archives of biochemistry and biophysics.
[121] A. A. Spector,et al. Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids. , 1999, American journal of physiology. Heart and circulatory physiology.
[122] J. Haeggström,et al. Evidence for a catalytic role of tyrosine 383 in the peptidase reaction of leukotriene A4 hydrolase. , 1995, European journal of biochemistry.
[123] R. Armstrong,et al. Microsomal and soluble epoxide hydrolases are members of the same family of C-X bond hydrolase enzymes. , 1994, Chemical research in toxicology.
[124] J. Haeggström,et al. Zinc and other divalent cations inhibit purified leukotriene A4 hydrolase and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes. , 1994, Archives of biochemistry and biophysics.
[125] F. Oesch,et al. An impaired peroxisomal targeting sequence leading to an unusual bicompartmental distribution of cytosolic epoxide hydrolase , 1991, FEBS letters.
[126] F. Oesch,et al. Distribution and inducibility of cytosolic epoxide hydrolase in male Sprague-Dawley rats. , 1986, Biochemical pharmacology.
[127] F. Oesch,et al. Cloning and molecular characterization of a soluble epoxide hydrolase from Aspergillus niger that is related to mammalian microsomal epoxide hydrolase. , 1999, The Biochemical journal.
[128] E. Jendraschak,et al. Isolation of human promoter regions by Alu repeat consensus-based polymerase chain reaction. , 1998, Genomics.
[129] C. Smith,et al. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer , 1999, British Journal of Cancer.
[130] S. Månér,et al. Induction of liver microsomal epoxide hydrolase, UDP-glucuronyl transferase and cytosolic glutathione transferase in different rodent species by 2-acetylaminofluorene or 3-methylcholanthrene. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.
[131] J. A. Bond,et al. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. , 1994, Carcinogenesis.
[132] F. Oesch,et al. Human liver cytosolic epoxide hydrolases. , 1988, European journal of biochemistry.
[133] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[134] B. Hammock,et al. Molecular cloning and expression of murine liver soluble epoxide hydrolase. , 1993, The Journal of biological chemistry.
[135] F. Oesch,et al. Recombinant expression of human microsomal epoxide hydrolase protects V79 Chinese hamster cells from styrene oxide‐ but not from ethylene oxide‐induced DNA strand breaks , 1997, Environmental and molecular mutagenesis.
[136] T. Komatsu,et al. Mouse liver musomal cholesterol epoxide hydrolase: A specific inhibition of its activity by 5,6α-Imino-5α-cholestan-3α-OL☆ , 1983 .